Prognostic Value of Myosteatosis and Creatinine-to-cystatin C Ratio in Patients With Pancreatic Ductal Adenocarcinoma
Clinical trial NCT05584852 · UNKNOWN
Trial details
- NCT number
- NCT05584852
- Sponsor
- The Affiliated Hospital of Qingdao University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-01
- Primary completion
- 2023-03-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.